"ortho-Aminobenzoates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benzoic acids, salts, or esters that contain an amino group attached to carbon number 2 or 6 of the benzene ring structure.
| Descriptor ID |
D062367
|
| MeSH Number(s) |
D02.241.223.100.050.400 D02.455.426.559.389.127.020.906
|
| Concept/Terms |
ortho-Aminobenzoates- ortho-Aminobenzoates
- ortho Aminobenzoates
- Anthranilates
- o-Aminobenzoates
- o Aminobenzoates
Anthranilic Acids- Anthranilic Acids
- Acids, Anthranilic
- ortho-Aminobenzoic Acids
- Acids, ortho-Aminobenzoic
- ortho Aminobenzoic Acids
- o-Aminobenzoic Acids
- Acids, o-Aminobenzoic
- o Aminobenzoic Acids
|
Below are MeSH descriptors whose meaning is more general than "ortho-Aminobenzoates".
Below are MeSH descriptors whose meaning is more specific than "ortho-Aminobenzoates".
This graph shows the total number of publications written about "ortho-Aminobenzoates" by people in this website by year, and whether "ortho-Aminobenzoates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2019 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "ortho-Aminobenzoates" by people in Profiles.
-
Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity. Brain. 2019 05 01; 142(5):1349-1364.
-
Stem cell proliferation is induced by apoptotic bodies from dying cells during epithelial tissue maintenance. Nat Commun. 2019 03 05; 10(1):1044.
-
Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats. Invest New Drugs. 2012 Jun; 30(3):853-61.
-
Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity. Cancer Res. 2010 Feb 01; 70(3):1111-9.
-
Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice. Invest New Drugs. 2011 Feb; 29(1):41-51.
-
The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression. Mol Cancer Ther. 2009 May; 8(5):1207-17.
-
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. Carcinogenesis. 2009 Jul; 30(7):1193-201.
-
Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression. Mol Cancer Ther. 2009 Mar; 8(3):533-42.
-
Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells. Cancer Res. 2007 Apr 01; 67(7):3286-94.
-
Relative allergenicity of cow's milk and cow's milk-based formulas in an animal model. Am J Med Sci. 1995 Nov; 310(5):183-7.